| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Pienta Kenneth serves as a Chief Medical Officer at CUE. Across recent SEC filings that breaks down to 2 buys and 4 sells. Those positions are worth an estimated $66K at current prices.
The biggest single holding is CUE (~$66K) as Chief Medical Officer. The recent filings there lean toward selling, a net 28,993 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2021 | CUE Cue Biopharma, Inc. | Chief Medical Officer | Sale+OE | 13,439 | $15.10 | $202,894.45 | -77.1% | -8.2% | -68.9% | |
| Feb 17, 2021 | CUE Cue Biopharma, Inc. | Chief Medical Officer | Sale+OE | 20,274 | $15.13 | $306,767.47 | -83.5% | - | - | |
| Jan 20, 2021 | CUE Cue Biopharma, Inc. | Chief Medical Officer | Buy | 2,720 | $15.07 | $40,979.52 | +136.0% | - | - | |
| Dec 27, 2017 | CUE Cue Biopharma, Inc. | Chief Medical Officer | Buy | 2,000 | $7.50 | $15,000.00 | New | - | - |